Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.31 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.31 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.31 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.31 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.31 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.31 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.31 |
| ▸ | HTR2B | P41595 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23475236 | 0.78 | GAA (0.38) | ALDH1A1HPGDLMNAHTTGPR55 | |
| SCHEMBL22561852 | 0.74 | LMNA (0.35) | ALDH1A1HPGDLMNAHTTGPR55 | |
| SCHEMBL21102094 | 0.73 | HTT (0.34) | LMNAHTTGPR55TRPA1PTGS1 | |
| SCHEMBL20388971 | 0.72 | NOTUM (0.39) | TRPA1 | |
| SCHEMBL13385327 | 0.69 | KDM4E (0.46) | ALDH1A1HPGDLMNAGPR55 | |
| SCHEMBL19145665 | 0.68 | AR (0.38) | ALDH1A1HPGD | |
| SCHEMBL598624 | 0.68 | LMNA (0.54) | ALDH1A1LMNAGPR55TRPA1PTGS1 | |
| SCHEMBL30165955 | 0.68 | LMNA (0.54) | ALDH1A1LMNAGPR55TRPA1PTGS1 | |
| SCHEMBL21183176 | 0.67 | AR (0.44) | — | |
| SCHEMBL24254520 | 0.67 | MCL1 (0.43) | ALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2019111225-A1 | COMPOUNDS AND METHODS FOR THE TREATMENT OF NON‑ALCOHOLIC STEATOHEPATITIS | AVALIV THERAPEUTICS (US) | 2019-06-13 | — | — | WO | disclosed |